Why Acetazolamide Is Contraindicated in Cirrhosis: Risk of Hepatic Encephalopathy

Mechanism: How a Diuretic Can Trigger Brain Dysfunction in Liver Disease

Acetazolamide, a carbonic anhydrase inhibitor used for glaucoma, altitude sickness, and epilepsy, reduces bicarbonate reabsorption in the proximal tubule, causing metabolic acidosis (lowered blood pH). In cirrhosis, this is dangerous.

The Cirrhotic Liver's Vulnerability

The cirrhotic liver already struggles to clear gut-derived toxins (ammonia, mercaptans, false neurotransmitters) due to portosystemic shunting and reduced hepatocyte function. Acidosis shifts ammonia equilibrium toward the neurotoxic NH₃ form, which crosses the blood-brain barrier more readily. Simultaneously, reduced bicarbonate impairs cerebral ammonia detoxification.

Hepatic Encephalopathy (HE)

HE is a spectrum of neuropsychiatric dysfunction—from subtle cognitive slowing (covert HE) to confusion, asterixis, seizures, and coma (overt HE). Precipitants include infection, GI bleeding, electrolyte shifts, sedatives, and—critically—metabolic acidosis.

Contraindication

Because acetazolamide-induced acidosis further impairs toxin clearance and promotes ammonia neurotoxicity in cirrhotic patients, it is contraindicated. Alternative agents (e.g., topical glaucoma drops, other antiepileptics) should be used.